Products

View as table Download

Her2 (ERBB2) Human Monoclonal Antibody [Clone ID: 4D5-8 (trastuzumab)]

TA385652

USD 523.00

2 Weeks

Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))

Applications	ELISA, FC, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD3E Mouse Monoclonal Antibody [Clone ID: OKT-3 (muromonab)]

TA385685

USD 523.00

2 Weeks

Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))

Applications	FC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD52 Human Monoclonal Antibody [Clone ID: Campath-1H]

TA385689

USD 523.00

2 Weeks

Recombinant Anti-CD52 (Clone Campath-1H)

Applications	ELISA, FC, IHC, WB
Reactivities	Human, Monkey
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD20 (MS4A1) Human Monoclonal Antibody [Clone ID: 10F381 (rituximab)]

TA385692

USD 523.00

2 Weeks

Recombinant Anti-CD20 (Clone 10F381 (rituximab))

Applications	FC
Reactivities	Human, Monkey
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

IL2 Receptor alpha (IL2RA) Human Monoclonal Antibody [Clone ID: Daclizumab]

TA385810

USD 523.00

2 Weeks

Recombinant Anti-IL-2R (Clone Daclizumab)

Applications	FC
Reactivities	Human, Monkey
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

EGFR Human Monoclonal Antibody [Clone ID: C225 (Cetuximab)]

TA385847

USD 523.00

2 Weeks

Recombinant Anti-EGFR (Clone C225 (Cetuximab))

Applications	FC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

TAG72 Mouse Monoclonal Antibody [Clone ID: B72.3 (Satumomab)]

TA385849

USD 523.00

2 Weeks

Recombinant Anti-Tumor associated glycoprotein (TAG) 72 (Clone B72.3 (Satumomab))

Applications	FC, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CEA Human Monoclonal Antibody [Clone ID: Arcitumomab]

TA385851

USD 523.00

2 Weeks

Recombinant Anti-carcinoembryonic antigen (CEA) (Clone Arcitumomab)

Applications	FC, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD40L (CD40LG) Human Monoclonal Antibody [Clone ID: hu5c8 (Ruplizumab)]

TA385961

USD 523.00

2 Weeks

Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))

Applications	FC, WB
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

TNF alpha (TNF) Human Monoclonal Antibody [Clone ID: CDP 571 (Humicade)]

TA385965

USD 523.00

2 Weeks

Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))

Applications	ELISA
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Integrin alpha 5 (ITGA5) Human Monoclonal Antibody [Clone ID: M200 (Volociximab)]

TA385968

USD 523.00

2 Weeks

Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))

Applications	ELISA, FC, IF, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

VEGFA Human Monoclonal Antibody [Clone ID: Bevacizumab]

TA386066

USD 523.00

2 Weeks

Recombinant Anti-VEGF (Clone Bevacizumab)

Applications	ELISA, FC, IP, WB
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Integrin alpha 4 (ITGA4) Human Monoclonal Antibody [Clone ID: Natalizumab]

TA386070

USD 523.00

2 Weeks

Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)

Applications	FC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

TNF alpha (TNF) Human Monoclonal Antibody [Clone ID: D2E7 (Adalimumab)]

TA386072

USD 523.00

2 Weeks

Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))

Applications	ELISA, IF, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

IL6R Human Monoclonal Antibody [Clone ID: rhPM-1 (Tocilizumab)]

TA386091

USD 523.00

2 Weeks

Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))

Applications	ELISA
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Active filters

Clonalities

Monoclonal

Edit Clear

Modifications

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Edit Clear

Filter by

Target Symbol

Choose Multiple...

Reactivities

Choose Multiple...

Applications

Choose Multiple...

Antibody Hosts

Choose Multiple...

Isotypes

Choose Multiple...

Conjugates

Unconjugated (15)

Assay Types

Indirect (7)

Antibodies

Primary Antibodies

TNF

CD3E

CD40LG

CD52

CEA

EGFR

ERBB2

IL2RA

IL6R

ITGA4

ITGA5

MS4A1

TAG72

VEGFA

Human

Monkey

ELISA

IHC

Human

Mouse

IgG1, kappa

IgG2a, kappa

Monoclonal

Unconjugated

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques.

Phospho-specific

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques.

This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

Modification

This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques.

This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column.

This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques.

This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Chicken scFv format, for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Chicken scFv format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created to reduce immunogenicity during in vivo applications.

This is a chimeric human antibody, based on the original mouse IgG2a format, created for improved compatibility with existing reagents, assays and techniques.

This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques.

This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques.

This is a chimeric recombinant Fab fragment created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls.

This is a recombinant chimeric Fab fragment created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls.

This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

This is a reformatted mouse IgG1 antibody, based on the original mouse IgG2a format, created for improved compatibility with existing reagents, assays and techniques.

This reformatted antibody was made using the variable domain sequences of the original mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques.

Indirect

HT BioMarker Screening/Drug Discovery

CAR T-cell

ADC

Neuroscience

Products

Active filters

Category

Clonalities

Modifications

Filter by

Target Symbol

Reactivities

Applications

Antibody Hosts

Isotypes

Conjugates

Assay Types

Viral Gene Delivery

ELISA Center

Other Tools

Hot Topics

HT BioMarker Screening/Drug Discovery

CAR T-cell

ADC

Oncology

Virus

Signal Transduction

Technology

Who we are

Company News

Careers

Products

Active filters

Category

Clonalities

Modifications

Filter by

Target Symbol

Reactivities

Applications

Antibody Hosts

Isotypes

Conjugates

Assay Types

Category

SubCategory

Target Symbol

Species

Reactivities

Applications

Antibody Hosts

Isotypes

Clonalities

Conjugates

Carrier-free

Knockout (KO) Validation

Recombinant

Expression Hosts

Biosimilar

Lentivirus

Tags

Vectors

Reporters

Modifications

Protein Source

Mutants

Assay Types

Assay Platforms

Disease States

Diagnosis

Tissues

TissueScan Types

QC Levels

C-Tag

Mammalian Cell Selection

Families

Pathways

Brands

Citations

Availabilities

__Category ID

__Matched ELISA Pair

__PT